Free Trial

Versant Venture Management, LLC Top Holdings and 13F Report (2024)

About Versant Venture Management, LLC

Investment Activity

  • Versant Venture Management, LLC has $63.57 million in total holdings as of September 30, 2024.
  • Versant Venture Management, LLC owns shares of 6 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
  • About 5.83% of the portfolio was sold this quarter.
  • This quarter, Versant Venture Management, LLC has purchased 8 new stocks and bought additional shares in 0 stocks.
  • Versant Venture Management, LLC sold shares of 0 stocks and completely divested from 2 stocks this quarter.

Largest Holdings

Contineum Therapeutics, Inc.
$17,573,640
Skye Bioscience, Inc.
$7,850,123

Sector Allocation Over Time

Map of 500 Largest Holdings ofVersant Venture Management, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$23,422,2550.0%498,55836.8%Medical
Contineum Therapeutics, Inc.
$17,573,6400.0%918,16327.6%Common Stock
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
$9,104,5000.0%2,646,65714.3%Medical
Skye Bioscience, Inc.
$7,850,1230.0%2,007,70412.3%Common Stock
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
$3,557,8830.0%506,8215.6%Medical
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$2,065,1110.0%3,561,1503.2%Medical
Passage Bio, Inc. stock logo
PASG
Passage Bio
$0$3,197,780 -100.0%00.0%Medical
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
$0$510,278 -100.0%00.0%Medical

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data